<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; an</title>
	<atom:link href="http://www.tapanray.in/tag/an/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Are Preventive Medicines always cost effective to be an area of focus in healthcare management?</title>
		<link>http://www.tapanray.in/are-preventive-medicines-always-cost-effective-to-be-an-area-of-focus-in-healthcare-management/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=are-preventive-medicines-always-cost-effective-to-be-an-area-of-focus-in-healthcare-management</link>
		<comments>http://www.tapanray.in/are-preventive-medicines-always-cost-effective-to-be-an-area-of-focus-in-healthcare-management/#comments</comments>
		<pubDate>Mon, 19 Mar 2012 00:00:21 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Always]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[area]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[effective]]></category>
		<category><![CDATA[focus]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Preventive]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=119</guid>
		<description><![CDATA[American Board of Preventive Medicine defines ‘Preventive Medicine’ as follows: “Preventive Medicine is the specialty of medical practice that focuses on the health of individuals, communities, and defined populations. Its goal is to protect, promote, and maintain health and well-being &#8230; <a href="http://www.tapanray.in/are-preventive-medicines-always-cost-effective-to-be-an-area-of-focus-in-healthcare-management/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/are-preventive-medicines-always-cost-effective-to-be-an-area-of-focus-in-healthcare-management/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Game Changer: Effective transition from ‘blockbuster’ to an integrated ‘niche buster’ plus &#8216;generic drugs&#8217; business model</title>
		<link>http://www.tapanray.in/the-game-changer-effective-transition-from-blockbuster-to-an-integrated-niche-buster-plus-generic-drugs-business-model/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-game-changer-effective-transition-from-blockbuster-to-an-integrated-niche-buster-plus-generic-drugs-business-model</link>
		<comments>http://www.tapanray.in/the-game-changer-effective-transition-from-blockbuster-to-an-integrated-niche-buster-plus-generic-drugs-business-model/#comments</comments>
		<pubDate>Sun, 20 Nov 2011 07:58:47 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[blockbuster]]></category>
		<category><![CDATA[buster]]></category>
		<category><![CDATA[Changer]]></category>
		<category><![CDATA[drugs. business]]></category>
		<category><![CDATA[effective]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[integrated]]></category>
		<category><![CDATA[model]]></category>
		<category><![CDATA[niche]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[plus]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=172</guid>
		<description><![CDATA[Since quite some time global pharmaceutical majors have been operating within the confines of high risk &#8211; high reward R&#38;D based business model with blockbuster drugs (annual sales of over US$ 1 billion). Blockbuster brands, mostly in the chronic-care segments &#8230; <a href="http://www.tapanray.in/the-game-changer-effective-transition-from-blockbuster-to-an-integrated-niche-buster-plus-generic-drugs-business-model/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-game-changer-effective-transition-from-blockbuster-to-an-integrated-niche-buster-plus-generic-drugs-business-model/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does India need an equivalent of ‘The Physician Payment Sunshine Act’ of the US for transparency in pharmaceutical marketing?</title>
		<link>http://www.tapanray.in/does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing</link>
		<comments>http://www.tapanray.in/does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing/#comments</comments>
		<pubDate>Mon, 14 Nov 2011 00:00:41 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[Code]]></category>
		<category><![CDATA[Compliance]]></category>
		<category><![CDATA[equivalent]]></category>
		<category><![CDATA[Ethics]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Payment]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Sunshine]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[transparency]]></category>
		<category><![CDATA[UCPMP]]></category>
		<category><![CDATA[USA]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=175</guid>
		<description><![CDATA[Currently a strong and palpable public sentiment against corruption has engulfed India albeit more than what we witness in movements like &#8216;Occupy Wall Street&#8217; against systemic corruption not only in the US but in a large number of cities across &#8230; <a href="http://www.tapanray.in/does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>&#8216;India Taskforce&#8217; takes the first step in an arduous task to bridge the trust deficit.</title>
		<link>http://www.tapanray.in/india-taskforce-takes-the-first-step-in-an-arduous-task-to-bridge-the-trust-deficit/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=india-taskforce-takes-the-first-step-in-an-arduous-task-to-bridge-the-trust-deficit</link>
		<comments>http://www.tapanray.in/india-taskforce-takes-the-first-step-in-an-arduous-task-to-bridge-the-trust-deficit/#comments</comments>
		<pubDate>Mon, 13 Jun 2011 00:00:31 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[arduous]]></category>
		<category><![CDATA[bridge]]></category>
		<category><![CDATA[deficit]]></category>
		<category><![CDATA[First]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[investments]]></category>
		<category><![CDATA[ministry of health]]></category>
		<category><![CDATA[MoH]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[step]]></category>
		<category><![CDATA[takes]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[task]]></category>
		<category><![CDATA[Taskforce]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[trust]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=244</guid>
		<description><![CDATA[To prepare a comprehensive long term strategy to unleash the growth potential of the Pharmaceutical Industry of India considering all its current issues, the Ministry of Health and Family Welfare announced constitution of a taskforce on March 15, 2011 involving &#8230; <a href="http://www.tapanray.in/india-taskforce-takes-the-first-step-in-an-arduous-task-to-bridge-the-trust-deficit/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/india-taskforce-takes-the-first-step-in-an-arduous-task-to-bridge-the-trust-deficit/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Social Media – an evolving new-age powerful communication tool for the Pharmaceutical Industry, both global and local</title>
		<link>http://www.tapanray.in/social-media-an-evolving-new-age-powerful-communication-tool-for-the-pharmaceutical-industry-both-global-and-local/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=social-media-an-evolving-new-age-powerful-communication-tool-for-the-pharmaceutical-industry-both-global-and-local</link>
		<comments>http://www.tapanray.in/social-media-an-evolving-new-age-powerful-communication-tool-for-the-pharmaceutical-industry-both-global-and-local/#comments</comments>
		<pubDate>Mon, 20 Dec 2010 01:00:48 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[attractiveness]]></category>
		<category><![CDATA[both]]></category>
		<category><![CDATA[communication]]></category>
		<category><![CDATA[evolving]]></category>
		<category><![CDATA[Facebook financial]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[local]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Media]]></category>
		<category><![CDATA[new-age]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[powerful]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Social]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[tool]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=332</guid>
		<description><![CDATA[David Edelman in his article titled, &#8220;Branding in the Digital Age:You&#8217;re Spending your Money in All the Wrong Places&#8221;, published in the &#8216;Harvard Business Review&#8217;  dated December 2010, commented the following: &#8220;Consumers today connect with brands in fundamentally new ways, often &#8230; <a href="http://www.tapanray.in/social-media-an-evolving-new-age-powerful-communication-tool-for-the-pharmaceutical-industry-both-global-and-local/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/social-media-an-evolving-new-age-powerful-communication-tool-for-the-pharmaceutical-industry-both-global-and-local/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Create, Deliver and Realize maximum value from a new product launch with an innovative Supply Chain Management system</title>
		<link>http://www.tapanray.in/create-deliver-and-realize-maximum-value-from-a-new-product-launch-with-an-innovative-supply-chain-management-system/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=create-deliver-and-realize-maximum-value-from-a-new-product-launch-with-an-innovative-supply-chain-management-system</link>
		<comments>http://www.tapanray.in/create-deliver-and-realize-maximum-value-from-a-new-product-launch-with-an-innovative-supply-chain-management-system/#comments</comments>
		<pubDate>Mon, 30 Aug 2010 01:00:49 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[create]]></category>
		<category><![CDATA[deliver]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[Heparin]]></category>
		<category><![CDATA[innovative]]></category>
		<category><![CDATA[launch]]></category>
		<category><![CDATA[logistics]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[maximum]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Realize]]></category>
		<category><![CDATA[SCS]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[system]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[value]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=381</guid>
		<description><![CDATA[Like in many other industries, effective supply-chain management (SCM) in the pharmaceutical industry involves a systematic process, spanning from procurement of raw, packaging and other related materials, converting those materials into finished goods stock keeping units (SKUs), inventory management of &#8230; <a href="http://www.tapanray.in/create-deliver-and-realize-maximum-value-from-a-new-product-launch-with-an-innovative-supply-chain-management-system/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/create-deliver-and-realize-maximum-value-from-a-new-product-launch-with-an-innovative-supply-chain-management-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Making quality medicines available at an affordable price – Are we &#8216;missing woods for the trees&#8217;?</title>
		<link>http://www.tapanray.in/making-quality-medicines-available-at-an-affordable-price-are-we-missing-woods-for-the-trees/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=making-quality-medicines-available-at-an-affordable-price-are-we-missing-woods-for-the-trees</link>
		<comments>http://www.tapanray.in/making-quality-medicines-available-at-an-affordable-price-are-we-missing-woods-for-the-trees/#comments</comments>
		<pubDate>Mon, 16 Aug 2010 01:00:24 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[at]]></category>
		<category><![CDATA[available]]></category>
		<category><![CDATA[DoP]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Making]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Missing]]></category>
		<category><![CDATA[MoH]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Quality]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[trees]]></category>
		<category><![CDATA[we]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[woods]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=387</guid>
		<description><![CDATA[On August 4, 2010 the Parliamentary standing committee for Health and Family Welfare in its 45th report, recommended the following to the ‘Rajya Sabha’ of the Parliament of India for ‘Making quality medicines available at an affordable price’ to the &#8230; <a href="http://www.tapanray.in/making-quality-medicines-available-at-an-affordable-price-are-we-missing-woods-for-the-trees/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/making-quality-medicines-available-at-an-affordable-price-are-we-missing-woods-for-the-trees/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>To restore patients’ confidence MCI has amended its regulations… to strengthen it further will the government consider an Indian version of ‘Physician Payment Sunshine Act’?</title>
		<link>http://www.tapanray.in/to-restore-patients-confidence-mci-has-amended-its-regulations-to-strengthen-it-further-will-the-government-consider-an-indian-version-of-physician-payment-sunshine-act/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=to-restore-patients-confidence-mci-has-amended-its-regulations-to-strengthen-it-further-will-the-government-consider-an-indian-version-of-physician-payment-sunshine-act</link>
		<comments>http://www.tapanray.in/to-restore-patients-confidence-mci-has-amended-its-regulations-to-strengthen-it-further-will-the-government-consider-an-indian-version-of-physician-payment-sunshine-act/#comments</comments>
		<pubDate>Mon, 08 Feb 2010 01:30:08 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[amended]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[Code]]></category>
		<category><![CDATA[confidence]]></category>
		<category><![CDATA[consider]]></category>
		<category><![CDATA[Council]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[DoP]]></category>
		<category><![CDATA[further]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[has]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[Malpractices]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[MCI]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Payment]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[regulations]]></category>
		<category><![CDATA[restore]]></category>
		<category><![CDATA[strengthen]]></category>
		<category><![CDATA[Sunshine]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[version]]></category>
		<category><![CDATA[Will]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=470</guid>
		<description><![CDATA[In today’s India, blatant commercialization of the noble healthcare services has reached its nadir, as it were, sacrificing the ethics and etiquettes both in medical and pharmaceutical marketing practices at the altar of unlimited greed. As a result of fast &#8230; <a href="http://www.tapanray.in/to-restore-patients-confidence-mci-has-amended-its-regulations-to-strengthen-it-further-will-the-government-consider-an-indian-version-of-physician-payment-sunshine-act/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/to-restore-patients-confidence-mci-has-amended-its-regulations-to-strengthen-it-further-will-the-government-consider-an-indian-version-of-physician-payment-sunshine-act/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Collaborative commercialization of inexpensive smaller incremental innovation in Chemistry will play an important role in bringing affordable new drugs or new drug delivery systems</title>
		<link>http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems</link>
		<comments>http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/#comments</comments>
		<pubDate>Mon, 28 Dec 2009 00:30:28 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[bringing]]></category>
		<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Collaborative]]></category>
		<category><![CDATA[commercialization]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[important]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[incremental]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[inexpensive]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[NDDS]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[or]]></category>
		<category><![CDATA[Oxford]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[play]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[role]]></category>
		<category><![CDATA[smaller]]></category>
		<category><![CDATA[systems]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[UK]]></category>
		<category><![CDATA[Will]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=685</guid>
		<description><![CDATA[It started in the 17th century: Alchemy, a medieval chemical science and speculative philosophy aiming to achieve the transmutation of the base metals into gold, searching for a universal cure for disease and indefinitely prolonging life, not considered a science &#8230; <a href="http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>For greater transparency in the relationship between physicians and the pharmaceutical companies, does India need an Act like, proposed ‘The Physician Payment Sunshine Act’ of the USA?</title>
		<link>http://www.tapanray.in/for-greater-transparency-in-the-relationship-between-physicians-and-the-pharmaceutical-companies-does-india-need-an-act-like-proposed-the-physician-payment-sunshine-act-of-the-usa/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=for-greater-transparency-in-the-relationship-between-physicians-and-the-pharmaceutical-companies-does-india-need-an-act-like-proposed-the-physician-payment-sunshine-act-of-the-usa</link>
		<comments>http://www.tapanray.in/for-greater-transparency-in-the-relationship-between-physicians-and-the-pharmaceutical-companies-does-india-need-an-act-like-proposed-the-physician-payment-sunshine-act-of-the-usa/#comments</comments>
		<pubDate>Mon, 16 Nov 2009 01:30:12 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[between]]></category>
		<category><![CDATA[Code]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Does]]></category>
		<category><![CDATA[greater]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[like]]></category>
		<category><![CDATA[Malpractices]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Payment]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[physicians]]></category>
		<category><![CDATA[proposed]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[relationship]]></category>
		<category><![CDATA[Sunshine]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[transparency]]></category>
		<category><![CDATA[USA]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=724</guid>
		<description><![CDATA[As we discussed earlier, to make the pharmaceutical companies disclose and report various types of payments made to the physicians, two Senators of the United States of America, Chuck Grassley and Herb Kohl introduced a bill called ‘The Physician Payment &#8230; <a href="http://www.tapanray.in/for-greater-transparency-in-the-relationship-between-physicians-and-the-pharmaceutical-companies-does-india-need-an-act-like-proposed-the-physician-payment-sunshine-act-of-the-usa/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/for-greater-transparency-in-the-relationship-between-physicians-and-the-pharmaceutical-companies-does-india-need-an-act-like-proposed-the-physician-payment-sunshine-act-of-the-usa/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
